Fulminant hepatic failure: summary of a workshop. Read more about Fulminant hepatic failure: summary of a workshop.
Interferon-alpha therapy for hepatitis C virus infection after liver transplantation. Read more about Interferon-alpha therapy for hepatitis C virus infection after liver transplantation.
Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Read more about Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease.
Liver transplantation for hepatitis C virus-related cirrhosis. Read more about Liver transplantation for hepatitis C virus-related cirrhosis.
Liver transplantation for hepatocellular carcinoma. Read more about Liver transplantation for hepatocellular carcinoma.
Cirrhosis of undefined pathogenesis: absence of evidence for unknown viruses or autoimmune processes. Read more about Cirrhosis of undefined pathogenesis: absence of evidence for unknown viruses or autoimmune processes.
Incidence and diagnostic features of macroregenerative nodules vs. small hepatocellular carcinoma in cirrhotic livers. Read more about Incidence and diagnostic features of macroregenerative nodules vs. small hepatocellular carcinoma in cirrhotic livers.
Hepatitis C viral infection in liver transplant recipients. Read more about Hepatitis C viral infection in liver transplant recipients.
Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Read more about Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure.
Azathioprine hepatotoxicity after liver transplantation. Read more about Azathioprine hepatotoxicity after liver transplantation.
